Cancer- The breaking news on the treatment, cure and diagnosis of cancer

 
 

 
 

  • Search for "cancer news"
  • S&P 500 ekes out record high as earnings roll in

    S&P 500 ekes out record high as earnings roll in
    The stock market eked out a record high Wednesday, as investors weighed positive earnings from the technology industry against disappointing news from Boeing and other companies.
  • Blount County walking horse trainer back in court after new soring violation

    Blount County walking horse trainer back in court after new soring violation
    A Tennessee walking horse trainer charged with animal cruelty was back in a Blount County courtroom Wednesday, just a week and a half after being cited for soring at a local horse show.
  • Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014

    Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014
    Third quarter net earnings per diluted share were $1.02 including impairment of equity investment; revenues increased 3 percent to $748 million impairment charge related to a portion of Varian's existing equity investment in Augmenix, a privately-held company developing minimally invasive hydrogels for radiotherapy.
  • 295% Pop: Too Late to Buy Puma Biotechnology Stock?

    295% Pop: Too Late to Buy Puma Biotechnology Stock?
    The news surprised investors, whose worries over side effects in previous trials caused shares to fall by more than 50%, as shares held short increased from 1.5 million to nearly 1.7 million, or roughly 8% of all Puma's shares available for trading.
  • Painful, Itchy Patches Could Be Sign of Skin Cancer

    Painful, Itchy Patches Could Be Sign of Skin Cancer
    "Patients sometimes have multiple lesions that are suspicious looking, and those that are itchy or painful should raise high concerns for non-melanoma skin cancers," study author Dr. Gil Yosipovitch, chairman of dermatology at Temple University School of Medicine, said in a Temple University Health System news release.
  • MD Anderson Cancer Center - News Releases
  • "Father of Tamoxifen" to Join MD Anderson

    "Father of Tamoxifen" to Join MD Anderson
    The University of Texas MD Anderson Cancer Center is pleased to announce that one of the world's preeminent experts in breast cancer research and treatment, V. Craig Jordan, Ph.D., will join the institution's efforts to end cancer.  Jordan is considered...
  • MD Anderson Ranked #2 in Annual U.S. News & World Report Survey

    MD Anderson Ranked #2 in Annual U.S. News & World Report Survey
    According to the annual "Best Hospitals" survey conducted by U.S. News & World Report, The University of Texas MD Anderson Cancer Center is ranked No. 2 in cancer care this year....
  • Study finds diagnosing physicians influence treatment decisions for prostate cancer patients

    Study finds diagnosing physicians influence treatment decisions for prostate cancer patients
    New research from The University of Texas MD Anderson Cancer Center is shedding light on the important role a diagnosing urologist plays in whether older men with low-risk prostate cancer receive treatment for their disease, and if so, the type...
  • MD Anderson researchers discover new route for ovarian cancer spread

    MD Anderson researchers discover new route for ovarian cancer spread
    Circulating tumor cells spread ovarian cancer through the bloodstream, homing in on a sheath of abdominal fatty tissue where it can grow and metastasize to other organs, scientists at The University of Texas MD Anderson Cancer Center report in Cancer...
  • Study Shows Restored Immunity for Cancer-Related Fungal Infections

    Study Shows Restored Immunity for Cancer-Related Fungal Infections
    A study at The University of Texas MD Anderson Cancer Center used the Sleeping Beauty gene transfer system to modify T cells in hopes of fighting major life-threatening infections caused by invasive Aspergillus fungus.  ...
  • Biocompare Cancer
  • Unique Study Focuses On Combined Treatment Approach For Locally Advanced Pancreatic Cancer

    Unique Study Focuses On Combined Treatment Approach For Locally Advanced Pancreatic Cancer
    LOS ANGELES (July 21, 2014) - Investigators at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute are developing a novel, multistep investigational treatment for one of the most complex and difficult-to-treat forms of the disease, locally advanced pancreatic cancer.
  • New Research Finds Pathogenic Connection Between Autoimmune Disorders And Cancer

    New Research Finds Pathogenic Connection Between Autoimmune Disorders And Cancer
    WASHINGTON -- Autoimmune disorders may share certain pathogenic mechanisms with cancer, according to a new report by George Washington University (GW) researcher Linda Kusner, Ph.D., published in PLOS ONE on July 22.
  • Viral Therapy Could Boost Limb-Saving Cancer Treatment

    Viral Therapy Could Boost Limb-Saving Cancer Treatment
    Viruses designed to target and kill cancer cells could boost the effectiveness of chemotherapy to the arms and legs and help avoid amputation, a new study reports.
  • New Accurate Epigenetic Test Could Eliminate Unnecessary Repeat Biopsies For Prostate Cancer

    New Accurate Epigenetic Test Could Eliminate Unnecessary Repeat Biopsies For Prostate Cancer
    New York, NY -- More than one million prostate biopsies are performed each year in the U.S. alone, including many repeat biopsies for fear of cancer missed. Therefore there is a need to develop diagnostic tests that will help avoid unnecessary repeat biopsies. Two independent trials have now validated the performance of an epigenetic test that could provide physicians with a better tool to help eliminate unnecessary repeat prostate biopsies, report investigators in The Journal of Urology®.
  • Increased Overall Survival For Advanced Stage NSCLC Patients Is Associated With Availability Of Less Toxic Chemotherapy.

    Increased Overall Survival For Advanced Stage NSCLC Patients Is Associated With Availability Of Less Toxic Chemotherapy.
    DENVER - A 10-year population-based study shows that increased availability of better systemic chemo- and targeted-therapies for patients with advanced non-small cell lung cancer (NSCLC) coincides with increased usage of these therapies. This in turn leads to a significant increase in overall survival.